๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—† A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—†
Markets ยท 15 min delay
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
ISEQ9,241.3โ–ฒ +0.62%
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
Updated 04 Jul 2026 ยท HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market โ€” 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
587 medicines starting with โ€œLโ€
MedicineActive substanceLicence holderStatus
Labetalol 5 mg/ml solution for injection/ infusion
PA22760/001/001
Labetalol hydrochloride S.A.L.F. S.p.A. Laboratorio Farmacologico Marketed
Labrycor 0.2 mg/ml concentrate for solution for infusion
PA23314/002/001
Isoprenaline hydrochloride Macure Healthcare Limited Not marketed
Lacosamide Accord 10 mg/ml solution for infusion
EU/1/17/1230/026-027
Lacosamide Accord Healthcare S.L.U. โ€”
Lacosamide Accord 100 mg film coated tablets
EU/1/17/1230/005-008
Lacosamide Accord Healthcare S.L.U. โ€”
Lacosamide Accord 150 mg film coated tablets
EU/1/17/1230/009-012
Lacosamide Accord Healthcare S.L.U. โ€”
Lacosamide Accord 200 mg film coated tablets
EU/1/17/1230/013-016
Lacosamide Accord Healthcare S.L.U. โ€”
Lacosamide Accord 50 mg film coated tablets
EU/1/17/1230/001-004
Lacosamide Accord Healthcare S.L.U. โ€”
Lacosamide Adroiq 10 mg/ml solution for infusion
EU/1/23/1732/001
Lacosamide Extrovis EU Kft. โ€”
Lacosamide Ascend 10 mg/ml syrup
PA23429/001/001
Lacosamide Ascend GmbH Not marketed
Lacosamide Fresenius Kabi 10 mg/ml solution for infusion
PA2059/078/001
Lacosamide Fresenius Kabi Deutschland GmbH Not marketed
Lacosamide Grindeks 100 mg film-coated tablets
PA22992/026/002
Lacosamide AS Grindeks Not marketed
Lacosamide Grindeks 150 mg film-coated tablets
PA22992/026/003
Lacosamide AS Grindeks Not marketed
Lacosamide Grindeks 200 mg film-coated tablets
PA22992/026/004
Lacosamide AS Grindeks Not marketed
Lacosamide Grindeks 50 mg film-coated tablets
PA22992/026/001
Lacosamide AS Grindeks Not marketed
Lacosamide Krka 100 mg film-coated tablets
PA1347/099/002
Lacosamide KRKA, d.d., Novo mesto Marketed
Lacosamide Krka 150 mg film-coated tablets
PA1347/099/003
Lacosamide KRKA, d.d., Novo mesto Marketed
Lacosamide Krka 200 mg film-coated tablets
PA1347/099/004
Lacosamide KRKA, d.d., Novo mesto Marketed
Lacosamide Krka 50 mg film-coated tablets
PA1347/099/001
Lacosamide KRKA, d.d., Novo mesto Marketed
Lacosamide UCB 10 mg/ml Syrup
EU/1/19/1383/003
Lacosamide UCB Pharma S.A. โ€”
Lacosamide UCB 100 mg Film-coated tablet
EU/1/19/1383/010-015
Lacosamide UCB Pharma S.A. โ€”
Lacosamide UCB 150 mg Film-coated tablet
EU/1/19/1383/016-021
Lacosamide UCB Pharma S.A. โ€”
Lacosamide UCB 200 mg Film-coated tablet
EU/1/19/1383/022-027
Lacosamide UCB Pharma S.A. โ€”
Lacosamide UCB 50 mg Film-coated tablet
EU/1/19/1383/004-009
Lacosamide UCB Pharma S.A. โ€”
Lactecon 3.335g/5ml oral solution
PA25506/003/001
Lactulose Cooper Consumer Health B.V. Not marketed
Lactulose 10 g/15 ml Oral Solution Sachets
PA0773/004/001
Lactulose Fresenius Kabi Austria GmbH Not marketed
Lactulose Fresenius 670mg/ml oral solution
PA0773/003/001
Lactulose Fresenius Kabi Austria GmbH Marketed
Laevolac Plum 10 g/15 ml oral solution
PA0773/005/001
Lactulose Fresenius Kabi Austria GmbH Not marketed
Lamictal 100 mg chewable/dispersible tablets
PA1077/061/009
Lamotrigine GlaxoSmithKline (Ireland) Limited Marketed
Lamictal 100 mg chewable/dispersible tablets
PPA0465/443/003
Lamotrigine PCO Manufacturing Ltd. โ€”
Lamictal 100 mg chewable/dispersible tablets.
PPA1463/066/002
Lamotrigine IMED Healthcare Ltd., โ€”
Lamictal 100 mg tablets
PA1077/061/003
Lamotrigine GlaxoSmithKline (Ireland) Limited Marketed
Lamictal 100 mg tablets
PPA0465/092/010
Lamotrigine PCO Manufacturing Ltd. โ€”
Lamictal 100 mg tablets
PPA1463/066/005
Lamotrigine IMED Healthcare Ltd., โ€”
Lamictal 100 mg tablets
PPA2306/024/001
Lamotrigine Originalis B.V. โ€”
Lamictal 100 mg Tablets
PPA23080/014/002
Lamotrigine Merit Pharmaceuticals Limited โ€”
Lamictal 2 mg chewable/dispersible tablets
PA1077/061/005
Lamotrigine GlaxoSmithKline (Ireland) Limited Marketed
Lamictal 200 mg chewable/dispersible tablets
PA1077/061/010
Lamotrigine GlaxoSmithKline (Ireland) Limited Marketed
Lamictal 200 mg chewable/dispersible tablets
PPA0465/092/009
Lamotrigine PCO Manufacturing Ltd. โ€”
Lamictal 200 mg chewable/dispersible tablets.
PPA1463/066/003
Lamotrigine IMED Healthcare Ltd., โ€”
Lamictal 200 mg tablets
PA1077/061/004
Lamotrigine GlaxoSmithKline (Ireland) Limited Marketed
Lamictal 200 mg tablets
PPA0465/092/013
Lamotrigine PCO Manufacturing Ltd. โ€”
Lamictal 200 mg tablets
PPA1463/066/009
Lamotrigine IMED Healthcare Ltd., โ€”
Lamictal 25 mg chewable/dispersible tablets
PA1077/061/007
Lamotrigine GlaxoSmithKline (Ireland) Limited Marketed
Lamictal 25 mg chewable/dispersible tablets
PPA0465/443/001
Lamotrigine PCO Manufacturing Ltd. โ€”
Lamictal 25 mg chewable/dispersible tablets.
PPA1463/066/006
Lamotrigine IMED Healthcare Ltd., โ€”
Lamictal 25 mg tablets
PA1077/061/001
Lamotrigine GlaxoSmithKline (Ireland) Limited Marketed
Lamictal 25 mg tablets
PPA0465/092/011
Lamotrigine PCO Manufacturing Ltd. โ€”
Lamictal 25 mg tablets
PPA1463/066/004
Lamotrigine IMED Healthcare Ltd., โ€”
Lamictal 25 mg tablets
PPA23080/014/001
Lamotrigine Merit Pharmaceuticals Limited โ€”
Lamictal 5 mg chewable/dispersible tablets
PA1077/061/006
Lamotrigine GlaxoSmithKline (Ireland) Limited Marketed
1 2 3 4 โ†’

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.